Epigenetic mechanisms for progression of prostate cancer.
about
Targeting the androgen receptor with steroid conjugatesTargeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domainsHistone H2A.Z deregulation in prostate cancer. Cause or effect?Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.Aberrant DNA methylation and prostate cancer.Ovarian stem cells: From basic to clinical applications.The emerging role of the PI3-K-Akt pathway in prostate cancer progression.Molecular pathology of prostate cancer.Regulators of gene expression as biomarkers for prostate cancerVersican: signaling to transcriptional control pathways.Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes.Prostate cancer epigenetics: a review on gene regulation.Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylationAndrogen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells.Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells.Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8.Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines.Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomasDNA hypermethylation status of multiple genes in prostate adenocarcinomas.Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.
P2860
Q26995692-2B081E6D-18BA-4F36-AFFD-681AAA55253EQ27675350-2BE04E1F-9857-47A6-8027-2E9C51469FE9Q28119073-26E2C3E2-88F3-45B4-A8DB-393C9E6686F4Q33962848-65F2C952-9246-4CCE-9193-8847AD11A736Q34233801-6F6E16D4-2C00-46C4-BC3F-1E5C493C4075Q35560819-B264BA43-38F4-4CE4-9904-607087CE2032Q35649789-637E99B0-4577-4B9D-839F-6249A0B42CA1Q36050987-5E3FEDD9-BB88-433C-AACB-6AACA9EEFF0AQ36249264-5CCBC4C6-39E8-4843-A800-487AA6ED61C8Q36439912-98BDDA48-7AA4-4B3C-8B3A-A2541B7FC2C6Q36538369-2C6CD39F-17BD-4E9E-8F4B-114C0EC83EACQ36737189-6A1864B1-AE28-4173-BFB5-1B98F587E317Q37380585-C3168D81-7BCC-46D0-9E16-27C73762C17FQ37388422-D5CD9C20-AF47-41FE-A24C-A4237E4D4143Q37418731-B0BC3D86-B15F-4D37-B7D8-50277098910EQ38331686-551D861B-92CD-4A2E-B46C-AB77BCCD1256Q38951931-4CFFAE3B-E3FA-442A-A6F3-71DB37759C4CQ39248189-2F83D8FD-70A4-4916-AF4F-B5C821E399E9Q40147477-AA1EFF3B-2A67-43DF-BB1B-D0DA71831437Q42048106-DF62CCFE-0B94-4C8C-B69A-895BD949244EQ44083581-EF8CEB06-3721-43A6-AB31-AF9607763645Q45885528-7536275A-1095-47E7-BB4F-10906C6E4F98
P2860
Epigenetic mechanisms for progression of prostate cancer.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Epigenetic mechanisms for progression of prostate cancer.
@ast
Epigenetic mechanisms for progression of prostate cancer.
@en
type
label
Epigenetic mechanisms for progression of prostate cancer.
@ast
Epigenetic mechanisms for progression of prostate cancer.
@en
prefLabel
Epigenetic mechanisms for progression of prostate cancer.
@ast
Epigenetic mechanisms for progression of prostate cancer.
@en
P356
P1476
Epigenetic mechanisms for progression of prostate cancer.
@en
P2093
P2888
P304
P356
10.1023/A:1006121219097
P577
1998-01-01T00:00:00Z
P6179
1013482824